Epostim

erythropoietin · GeneMedix Plc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Epostim, covering 2011-04-06 to 2011-04-19. Get the full timeline:

Most recent: EMA Application withdrawn: Epostim (epoetin alfa) — Reliance GeneMedix Plc